Analysis

Natco Pharma Limited (NATCOPHARM) Stock Analysis

Natco Pharma Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to NATCOPHARM.

websiteNATCOPHARM/analysis/NATCOPHARM

Natco Pharma Limited

Natco Pharma Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to NATCOPHARM.

Stock profile

Ticker

NATCOPHARM

Asset type

Stock

Market cap

$1.68B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

INR

Ticker listings

Natco Pharma Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

NATCOPHARM primary listing

Latest Natco Pharma Limited news

Press Release Jun 03 2026

Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Er...

India’s Natco Pharma to expand into Nigeria, demerge agrochemicals unit

India’s Natco Pharma to expand into Nigeria, demerge agrochemicals

Press Release Mar 20 2026

Natco Pharma Limited has informed the Exchange regarding a press release dated March 20, 2026, titled "NATCO Pharma Launches Semaglutide Generic Injection Multi Dose Vials in In...

Press Release Mar 03 2026

Natco Pharma Limited has informed the Exchange regarding a press release dated March 03, 2026, titled "NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst®) in ...

Natco Pharma Limited Press Release Mar 03 2026

Natco Pharma Limited has informed the Exchange regarding a press release dated March 03, 2026, titled "NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst®) in ...

Natco Pharma Limited (NATCOPHARM) Stock Analysis